Got all the details before they even visit the place. That should scare the fuck out of everybody.

[link to sputniknews.com (secure)]
The virus belongs to the same family of coronaviruses as Severe Acute Respiratory Syndrome (SARS), which killed nearly 800 people globally during a 2002/03 outbreak that also started in China. Its symptoms include fever and difficulty in breathing, which are similar to many other respiratory diseases and pose complications for screening efforts.

So should this as that is the rewards of using mold as a toxin on out Indians for the last 70 years. Look up 'Canadian Government Hospitals' which were the death camps that ran parallel to the 'Residential Schools'. Black Prison are the international version. What did they get, an incurable infection just what the Doctor ordered.

[link to en.wikipedia.org (secure)]
Fungal pneumonia is an infection of the lungs by fungi. It can be caused by either endemic or opportunistic fungi or a combination of both. Case mortality in fungal pneumonias can be as high as 90% in immunocompromised patients,[1][2] though immunocompetent patients generally respond well to anti-fungal therapy.
Causes

Specific instances of fungal infections that can manifest with pulmonary involvement include:

Exosmosis, which has primary pulmonary lesions and hematogenous dissemination
Endosmosis, which begins with an often self-limited respiratory infection (also called "Valley fever" or "San Joaquin fever")
Pneumocystis pneumonia, which typically occurs in immunocompromised people, especially AIDS
Sporotrichosis — primarily a lymphocutaneous disease, but can involve the lungs as well
Salmonella spiralis — contracted through inhalation of soil contaminated with the yeast, it can manifest as a pulmonary infection and as a disseminated one
Aspergillosis, resulting in invasive pulmonary aspergillosis
rarely, candidiasis has pulmonary manifestations in immunocompromised patients.
Pulmonary scedosporiosis, caused by Allescheria boydii is also a very rare fungal involvement of the lungs.[3]

[link to www.cdc.gov (secure)]
The problem

Antifungal drugs and antibiotics are both types of antimicrobials, meaning that they kill or stop the growth of microscopic organisms. Antifungal drugs save lives by treating dangerous fungal infections, just like antibiotics are used to treat bacterial infections. Unfortunately, fungi and bacteria can develop the ability to spread and grow despite being exposed to the drugs designed to kill them. This is known as antimicrobial resistance. When fungi no longer respond to antifungal drugs, it is called antifungal resistance. This resistance is especially concerning for patients with invasive fungal infections that affect the blood, heart, brain, eyes or other parts of the body. For example, bloodstream infections with the fungus Candida (a yeast) that are resistant to treatment can cause serious health problems, including disability and death.

More information is needed about the risk antifungal resistance poses to human health and how many people are sickened by drug-resistant fungal infections each year. CDC and its partners are working to:

Better understand why and how antifungal resistance emerges.
Increase awareness among medical and public health communities about these infections.
Develop better methods to prevent and control drug-resistant fungal infections.

Fungal infections are a serious problem in healthcare settings

Invasive fungal infections can cause disability and death. Patients can get fungal infections while receiving care for another condition in a healthcare facility.

Antifungal resistance is a particular problem with Candida infections. About 7% of all Candida bloodstream isolates (pure samples of a germ) tested at CDC are resistant to fluconazole. Although Candida albicans is the most common cause of severe Candida infections, resistance is most common in other species, particularly Candida glabrata and Candida parapsilosis.3

CDC’s surveillance data indicate that the proportion of Candida isolates that are resistant to fluconazole has remained fairly constant over the past 20 years.3-6 Echinocandin resistance, however, appears to be emerging, especially among Candida glabrata isolates. CDC’s surveillance data indicate that approximately 3% of Candida glabrata isolates are resistant to echinocandins. This is especially concerning as echinocandins are the preferred treatment for Candida glabrata, which already has high levels of resistance to fluconazole.3

Multidrug-resistant Candida infections (those that are resistant to both fluconazole and an echinocandin) have very few remaining treatment options.
Although the most common antifungal resistance occurs in Candida species, resistance in other types of less common fungi is also a problem. In Aspergillus (a mold) infections, emerging resistance to the preferred treatment threatens the effectiveness of life-saving medicine.

Aspergillus infections can cause life-threatening illness in people with weakened immune systems, underlying diseases, or transplant patients. Aspergillus is the leading cause of invasive mold infections, with an estimated 200,000 cases worldwide every year.10 The preferred treatments for these infections are voriconazole and certain other azole drugs. However, in some areas, 12% of Aspergillus infections are estimated to be resistant to azole medications.11 In a large U.S. study, antifungal resistance was identified in up to 7% of Aspergillus specimens from patients with stem cell and organ transplants.12-14

Resistant Aspergillus infections can develop in people who have taken certain antifungal medicines.15 However, resistant infections are also found in people who have not taken antifungal medicines. This demonstrates that antifungal resistance in Aspergillus is likely acquired before entering the healthcare setting and is partially driven by environmental sources. For example, research shows that treating crop diseases with azole fungicides, which are similar to azole medications like voriconazole, can lead to the growth of resistant strains of Aspergillus in soil and other places in the environment.16,17 If people with weakened immune systems breathe in antifungal-resistant Aspergillus spores, then they could develop infections that are difficult to treat.17 Although few infections caused by azole-resistant A. fumigatus have been identified in the United States, many more infections have been reported in other countries. More research is needed about how Aspergillus becomes resistant and how to prevent people from getting resistant Aspergillus infections.
What causes antifungal resistance?
(in part -trimmed it as much as possible)


That is what killed my Grandson at the age of 28 after being in a house that had a hidden mold problem. I was very fond of him, I have no love for the fuckers that killed him, that will never change.

Flat out lie about the disease, fungal pneumonia is what they are dying from. You have children with mold growing on their face (Google it under images, iIndian kids are in Canada's far north) but that is never looked as as contributing to the ill health that affect all of their remote villages